3/13
02:48 pm
clnn
Clene (CLNN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $48.00 price target on the stock.
Medium
Report
Clene (CLNN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $48.00 price target on the stock.
3/12
04:57 pm
clnn
Clene (CLNN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $23.00 price target on the stock.
Medium
Report
Clene (CLNN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $23.00 price target on the stock.
3/12
08:38 am
clnn
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights [Yahoo! Finance]
Medium
Report
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights [Yahoo! Finance]
3/12
08:00 am
clnn
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
Medium
Report
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
2/26
04:14 pm
clnn
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway [Yahoo! Finance]
Low
Report
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway [Yahoo! Finance]
2/24
08:00 am
clnn
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
Medium
Report
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
2/19
08:53 am
clnn
Clene to Present at the Emerging Growth Conference [Yahoo! Finance]
Medium
Report
Clene to Present at the Emerging Growth Conference [Yahoo! Finance]
2/19
08:30 am
clnn
Clene to Present at the Emerging Growth Conference
Medium
Report
Clene to Present at the Emerging Growth Conference